IIn the United States, there has been a growing interest in tesamorelin peptide with medical practitioners and researchers still researching on growth hormone-releasing hormone (GHRS) analogues. Tesamorelin has been touted in online forums as an agent to improve body composition, fat in the belly, recovery and aging healthily, yet it is necessary to disassociate scientifically proven medical application and marketing propaganda.
When you are looking to find the best tesamorelin peptide in USA, price or popularity should not be your first criteria, but it should be legitimacy, quality and regulatory approval.
Currently, the United States has only one approved tesamorelin medication that is currently being marketed under the brand name of EGRIFTA by Theratechnologies. It is not recommended as a general weight-loss drug, but it has been specifically approved to decrease excess abdominal visceral fat in HIV-associated lipodystrophy.
What Is Tesamorelin Peptide?
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH).
Instead of providing growth hormone per se, tesamorelin provokes the pituitary gland to secrete the growth hormone of the body. This further enhances the circulating insulin-like growth factor-1 (IGF-1) which affect a number of metabolic processes.
Tesamorelin has been through a lot of clinical trials of its approved indication unlike many peptides available over the internet to be used in research.
What Is the Best Tesamorelin Peptide in USA?
1. EGRIFTA WR (Tesamorelin)
Manufacturer: Theratechnologies
FDA Status: FDA Approved
Prescription Required: Yes
EGRIFTA WR is the latest prescription drug in the United States that is a version of tesamorelin that has been approved by the FDA. It has been created to be easier to prepare than older preparations, but it still should have the indicated approved indication of HIV-associated lipodystrophy.
Why it ranks first
- FDA-approved prescription medicine
- Manufactured under pharmaceutical quality standards
- Clinically studied
- Consistent manufacturing quality
- Physician supervision
- FDA-reviewed safety information
2. EGRIFTA SV
Before EGRIFTA WR, EGRIFTA SV became the standard prescription formulation of tesamorelin.
It remains an FDA-approved prescription medicine for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy.
Why FDA Approval Matters
In selecting a tesamorelin product, the FDA approval entails a significant guarantee in terms of quality, purity and consistency of manufacture and for the information on prescribing reviewed. Most products sold on the Internet under the label of research peptides are not approved as drugs by the FDA, and their identity, sterility, potency, or purity may not be confirmed separately. The products approved by the FDA use are produced under the regulated pharmaceutical standards where research-use products are meant to be used in laboratory research, but not in clinical use.
Potential Benefits of Tesamorelin
Clinical studies of FDA-approved tesamorelin have shown benefits for its approved patient population, including:
- Reduction in excess visceral abdominal fat
- Improvement in waist circumference
- Increased endogenous growth hormone release
- Increased IGF-1 levels
- Improved body composition in HIV-associated lipodystrophy
These findings apply to the approved medical indication and should not be generalized to healthy individuals or used as evidence for cosmetic weight loss.
Is Tesamorelin Approved for Weight Loss?
No.
One of the biggest misconceptions surrounding tesamorelin is that it is a weight-loss drug.
According to the FDA prescribing information, tesamorelin is not indicated for weight management. Its approved use is limited to reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy.
How to Choose the Best Tesamorelin in USA
When evaluating tesamorelin products, consider the following:
- FDA approval status
- Prescription availability
- Manufacturer reputation
- Product authenticity
- Professional medical supervision
- Pharmacy sourcing
Avoid assuming that a lower-priced online product offers the same quality or safety as an approved prescription medicine.
Are Research Peptides the Same?
No.
A large host of websites promote tesamorelin as an experimental peptide. Research peptides are typically not regulated by the FDA to be used routinely in clinical practice in the US, like commercial prescription drugs, and are only used in the laboratory. The quality, sterility, concentration and purity of the products can differ significantly as per the supplier. Due to this reason, research products ought not to be regarded as substitutes to a prescription formulation that is approved by the FDA.
Who May Benefit from Prescription Tesamorelin?
The approved indication by FDA only applies to adults with HIV who experience excess visceral fat in the abdomen related to lipodystrophy.
Tesamorelin should be used based on the medical history, drugs, and overall health of an individual. A medical practitioner can say whether or not the endorsed indication will suit and whether or not treatment is suitable.
Frequently Asked Questions
What is the best tesamorelin peptide in USA?
Among approved prescription products, EGRIFTA WR is the newest FDA-approved tesamorelin formulation available in the United States, while EGRIFTA SV is also an FDA-approved option.
Is tesamorelin FDA approved?
Yes. Tesamorelin is FDA approved under the EGRIFTA brand for reducing excess abdominal fat in adults with HIV-associated lipodystrophy.
Can tesamorelin be purchased without a prescription?
FDA-approved tesamorelin products require a prescription in the United States.
Is tesamorelin used for bodybuilding?
Although discussed in bodybuilding communities, this is not an FDA-approved indication, and evidence from approved clinical studies should not be extrapolated to those uses.
Is tesamorelin the same as growth hormone?
No. Tesamorelin stimulates the body’s own release of growth hormone rather than supplying growth hormone directly.
Final Thoughts
In search of the fastest tesamorelin peptide in USA, the brightest argument in favor of using a prescription product, which is approved by FDA, is obvious, not an unverified research peptide. Nowadays, tesamorelin has been FDA-approved and exists in two formulations as EGRIFTA WR and EGRIFTA SV in the United States to treat excess visceral abdominal fat that is a result of lipodystrophy caused by HIV.
Even though tesamorelin is the subject of ongoing interest regarding possible off-label use, it can hardly be regarded as a weight-loss drug or an anti-aging treatment, according to the suggested FDA-approved uses. Every person who thinks about using tesamorelin should find a qualified medical professional, who will provide information on whether or not it can be used in certain medical conditions of his or her situation.